Medicef Pharma Limited, a active public limited company, was established on 16 October 2012 in Kasauli, Himachal Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100DL2012PTC243670. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.10 M.
Formerly known as Medicef Pharma Private Limited. It upholds a compliant status. Its leadership includes Nilesh Narendrakumar Ranka (Director), Parveen Kumar (Director), Dhananjay Kumar Vishwakarma (Director). Past directors included Vijay Kumar Aggarwal, Sanjeev Goel, Vivek Kumar Rana. It holds ₹36.92 Cr open charges and ₹10.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 28, 29 & 48, Phase - 1, Epip, Jharmajri, Kasauli, Himachal Pradesh, 174103.
U24100HP2012PLC011243
011243
16 October 2012
₹5.00 Cr
₹0.10 M
Roc Himachal Pradesh
Unlisted
Active
Explore comprehensive insights into Medicef Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nilesh Narendrakumar Ranka | Director | 12 Feb 2024 | Current |
| Parveen Kumar | Director | 29 Jan 2024 | Current |
| Dhananjay Kumar Vishwakarma | Director | 29 Jan 2024 | Current |
| Anish Kumar Rana | Director | 29 Jan 2024 | Current |
| Satyanaraian Gupta | Director | 29 Jan 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jan 2024 | Past |
| Pramod Abcsdd | Director | 23 Jul 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Medicef Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹369,200,000.00
₹104,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2024 | Dbs Bank Ltd | ₹25.00 Cr | Open |
| 20 Sep 2023 | Others | ₹9.42 Cr | Open |
| 20 Sep 2023 | Others | ₹5.00 M | Open |
| 20 Sep 2023 | Others | ₹2.00 Cr | Open |
| 26 Aug 2022 | Others | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medicef Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medicef Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicef Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Dbs Bank Ltd of Rs. 25.00 Cr registered on 19 Feb 2024 with Charge ID 100868649 was modified on 30 Jan 2025. was completed.
The activity A charge with Others of Rs. 9.42 Cr registered on 20 Sep 2023 with Charge ID 100788792 was modified on 30 Jan 2025. was completed.
The activity A charge with Others of Rs. 0.50 Cr registered on 20 Sep 2023 with Charge ID 100788791 was modified on 30 Jan 2025. was completed.
Medicef Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Medicef Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh. was completed.
The activity A charge with Dbs Bank Ltd amounted to Rs. 25.00 Cr with Charge ID 100868649 was registered on 19 Feb 2024. was completed.
The CIN of Medicef Pharma Limited is U24100HP2012PLC011243.
Medicef Pharma Limited is headquartered at Plot No. 28, 29 & 48, Phase - 1, Epip, Jharmajri, Kasauli, Himachal Pradesh, 174103.
Medicef Pharma Limited was incorporated on 16 October 2012.
The current directors of Medicef Pharma Limited are
The primary industry of Medicef Pharma Limited is Trade.
Medicef Pharma Limited is unlisted.
The authorized capital of Medicef Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹0.10 M.
The compliance status of Medicef Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX